Immune Checkpoint Inhibitors Market with Current Trends Analysis,2027 Immune Checkpoint Healthcare | Page 6

Immune Checkpoint Inhibitors Market Regulations and Competitive
Landscape Outlook to 2027
immnuo-oncology research and expand its oncology business.
Asia Pacific is the fastest growing region in the immune checkpoint inhibitors market as there are number
of research collaborations of international players with companies from this region. For instance, Bristol-
Myers Squibb received Japanese approval for Opdivo in 2014, through partnership with Ono
Pharmaceuticals.
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3326
Immune Checkpoint Inhibitors Market: Key Market Participants
Some of the market contributors to the immune checkpoint inhibitors market are Bristol-Myers
Squibb, Merck & Co., Inc., Roche, AstraZeneca, Merck KGaA, Ono Pharmaceutical Co., Ltd., Novartis
International AG, Juno Therapeutics and Kite Pharma.
©2015 Future Market Insights, All Rights Reserved
6